002907.SZ
002907.SZ
CNE100003308
PHARSCIN PHARMA
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 827.144.563 774.819.867
6.8%
Cost of Revenue 352.473.143 331.050.582
6.5%
Gross Profit 474.671.420 443.769.284
7.0%
405.052.108 358.668.059
12.9%
Operating Income 69.619.312 85.101.226
18.2%
Pretax Income 77.456.538 93.441.939
17.1%
Net Income Common Stockholders 65.086.781 76.730.225
15.2%
-- --
--
-- --
--
ende